Sandbox: Difference between revisions
Jump to navigation
Jump to search
Ochuko Ajari (talk | contribs) No edit summary |
Rim Halaby (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
==Management== | |||
{{familytree/start |summary=Cholangitis}} | |||
{{familytree | | | | | | | A01 | | |A01=<div style="float: left; text-align: left; line-height: 150% ">'''Characterize the symptoms:''' <br> ❑ RUQ abdominal pain <br> ❑ Intermittent fever &/or chills<br> ❑ Jaundice<br> ❑ Lethargy or confusion </div> }} | |||
{{familytree/start}} | {{familytree | | | | | | | |!| | |}} | ||
{{familytree | | | | | | | | {{familytree | | | | | | | B01 | | B01=<div style="float: left; text-align: left; line-height: 150% ">'''Examine the patient:'''<BR>❑ Altered mental status<BR>❑ Febrile<BR>❑ Dehydrated<BR>❑ Jaundice<BR>❑ Hypotension<BR>❑ Tachycardia<BR>❑ Dyspnea<BR>❑ Hypoxemia<BR>❑ Abdominal tenderness</div>}} | ||
{{familytree | | | | | | | |!| | |}} | |||
{{familytree | | | | | | | | | | {{familytree | | | | | | | C01 | | C01=<div style="float: left; text-align: left; line-height: 150% ">'''Order laboratory tests:'''<br>❑ CBC<br>❑ BMP<br>❑ CRP<br>❑ Total bilirubin<br>❑ Direct bilirubin<br>❑ Albumin<br>❑ AST<br>❑ ALT<br>❑ Alkaline phosphatase<br>❑ GGT<br>❑ Amylase<br>❑ Lipase</div>}} | ||
{{familytree | | | | | | | |!| | |}} | |||
{{familytree | | | | | | | D01 | | D01=<div style="float: left; text-align: left; line-height: 150% ">'''[[Cholangitis resident survival guide#Diagnostic Criteria|Diagnostic criteria:]]'''<ref name="Mayumi-2013">{{Cite journal | last1 = Mayumi | first1 = T. | last2 = Someya | first2 = K. | last3 = Ootubo | first3 = H. | last4 = Takama | first4 = T. | last5 = Kido | first5 = T. | last6 = Kamezaki | first6 = F. | last7 = Yoshida | first7 = M. | last8 = Takada | first8 = T. | title = Progression of Tokyo Guidelines and Japanese Guidelines for management of acute cholangitis and cholecystitis. | journal = J UOEH | volume = 35 | issue = 4 | pages = 249-57 | month = Dec | year = 2013 | doi = | PMID = 24334691 }}</ref><br>❑ Systemic inflammation | |||
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | | | :❑ Fever >38℃ and/or shaking chills | ||
:❑ WBC (×1000/μl) <4, or >10 | |||
:❑ CRP (mg/dl) ≥1<br> | |||
❑ Cholestasis | |||
:❑ Jaundice with total bilirubin ≥2 (g/dl) | |||
:❑ ALP (IU) >1.5×STD | |||
{{familytree | :❑ GGT (IU) >1.5×STD | ||
:❑ AST (IU) >1.5×STD | |||
:❑ ALT (IU) >1.5×STD<br> | |||
❑ Imaging | |||
:❑ Biliary dilatation | |||
:❑ Evidence of etiology (stricture, stone, stent etc.)</div>}} | |||
{{familytree | | | | | | | |!| | |}} | |||
{{familytree | | | | | | | E01 | | |E01=<div style="float: left; text-align: left; line-height: 150% "><BR>❑ Hospital admission<BR>❑ NPO<br>❑ IVF & correct electrolyte abnormalities<br>❑ Blood C&S<br>❑ Empiric IV antibiotics<ref name="Solomkin-2003">{{Cite journal | last1 = Solomkin | first1 = JS. | last2 = Mazuski | first2 = JE. | last3 = Baron | first3 = EJ. | last4 = Sawyer | first4 = RG. | last5 = Nathens | first5 = AB. | last6 = DiPiro | first6 = JT. | last7 = Buchman | first7 = T. | last8 = Dellinger | first8 = EP. | last9 = Jernigan | first9 = J. | title = Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections. | journal = Clin Infect Dis | volume = 37 | issue = 8 | pages = 997-1005 | month = Oct | year = 2003 | doi = 10.1086/378702 | PMID = 14523762 }}</ref> | |||
:❑ Ceftriaxone 1 g IV every 24 hours + Metronidazole 500 mg IV every 8 hours | |||
'''or''' | |||
:❑ Ciprofloxacin 400 mg IV every 12 hours/Levofloxacin 500 or 750 mg IV once daily + Metronidazole 500 mg IV every 8 hours<br> | |||
❑ Acute pain management | |||
:❑ Ketorolac 30-60 mg IM/IV single dose | |||
'''or''' | |||
:❑ Opioids until drainage or surgical intervention if ketorolac is contraindicated/pain not improving<br> | |||
❑ [[Cholangitis resident survival guide#Severity Assessment Criteria|Assess severity]]<ref name="Mayumi-2013">{{Cite journal | last1 = Mayumi | first1 = T. | last2 = Someya | first2 = K. | last3 = Ootubo | first3 = H. | last4 = Takama | first4 = T. | last5 = Kido | first5 = T. | last6 = Kamezaki | first6 = F. | last7 = Yoshida | first7 = M. | last8 = Takada | first8 = T. | title = Progression of Tokyo Guidelines and Japanese Guidelines for management of acute cholangitis and cholecystitis. | journal = J UOEH | volume = 35 | issue = 4 | pages = 249-57 | month = Dec | year = 2013 | doi = | PMID = 24334691 }}</ref></div>}} | |||
{{familytree | | | |,|-|-|-|+|-|-|-|.| |}} | |||
{{familytree | | | F01 | | F02 | | F03 | | |F01=Grade 1 (Mild)|F02= Grade 2 (Moderate)|F03= Grade 3 (Severe)}} | |||
{{familytree | | | |!| | | |!| | | |!| | |}} | |||
{{familytree | | | G01 | | G02 | | G03 | | G01=<div style="float: left; text-align: left; line-height: 150% ">❑ NPO<br>❑ IVF & correct electrolyte abnormalities<br>❑ IV antibiotics (full dose)<br>❑ IV pain management w/ analgesics<br>❑ [[Cholangitis resident survival guide#Severity Assessment Criteria|Assess severity]] | |||
:❑ Within 24 hours after diagnosis (every 6-12 hours) | |||
:❑ During the time zone of 24-48 hours (every 6-12 hours)</div>|G02=<div style="float: left; text-align: left; line-height: 150% ">❑ NPO<br>❑ IVF & correct electrolyte abnormalities<br>❑ IV antibiotics (full dose)<br>❑ IV pain management w/ analgesics<br>❑ [[Cholangitis resident survival guide#Severity Assessment Criteria|Assess severity]] | |||
== | :❑ Within 24 hours after diagnosis (every 6-12 hours) | ||
:❑ During the time zone of 24-48 hours (every 6-12 hours)<br>❑ Immediate biliary tract drainage within 24-48 hours</div>|G03=<div style="float: left; text-align: left; line-height: 150% ">❑ NPO<br>❑ IVF & correct electrolyte abnormalities<br>❑ IV antibiotics (full dose)<br>❑ IV pain management w/ analgesics<br>❑ [[Cholangitis resident survival guide#Severity Assessment Criteria|Assess severity]] | |||
:❑ Within 24 hours after diagnosis (every 6-12 hours) | |||
:❑ During the time zone of 24-48 hours (every 6-12 hours)<br> | |||
❑ | ❑ Immediate organ support | ||
:❑ NIPPV/ IPPV | |||
:❑ Vasopressors<br> | |||
--- | ❑ Urgent biliary tract drainage</div>}} | ||
{{familytree | |,|-|^|-|.| | |!| | | |!| |}} | |||
{{familytree | H01 | | H02 | |!| | | |!| | H01=Improvement|H02=No improvement within the first 24 hours}} | |||
= | {{familytree | |!| | | |!| | |!| | | |!| |}} | ||
{{familytree | I01 | | I02 | |!| | | |!| | I01=Finish antibiotic course|I02=Immediate biliary tract drainage within 24 hours}} | |||
{{familytree | |`|-|v|-|'| | |!| | | |!| |}} | |||
{{familytree | | | | | | | | | | | | | |!| | | | | {{familytree | | | |`|-|-|-|-|+|-|-|-|'| |}} | ||
{{familytree | | | | | | | | | | {{familytree | | | | | | | | J01 | | | | J01=Treatment for etiology if still needed (endoscopic treatment, percutaneous treatment, or operative intervention)}} | ||
{{familytree | | | | | | | | | | | | | |||
{{familytree/end}} | {{familytree/end}} |
Revision as of 17:03, 21 January 2014
Management
Characterize the symptoms: ❑ RUQ abdominal pain ❑ Intermittent fever &/or chills ❑ Jaundice ❑ Lethargy or confusion | |||||||||||||||||||||||||||||
Examine the patient: ❑ Altered mental status ❑ Febrile ❑ Dehydrated ❑ Jaundice ❑ Hypotension ❑ Tachycardia ❑ Dyspnea ❑ Hypoxemia ❑ Abdominal tenderness | |||||||||||||||||||||||||||||
Order laboratory tests: ❑ CBC ❑ BMP ❑ CRP ❑ Total bilirubin ❑ Direct bilirubin ❑ Albumin ❑ AST ❑ ALT ❑ Alkaline phosphatase ❑ GGT ❑ Amylase ❑ Lipase | |||||||||||||||||||||||||||||
Diagnostic criteria:[1] ❑ Systemic inflammation
❑ Cholestasis
❑ Imaging
| |||||||||||||||||||||||||||||
❑ Hospital admission ❑ NPO ❑ IVF & correct electrolyte abnormalities ❑ Blood C&S ❑ Empiric IV antibiotics[2]
or
❑ Acute pain management
or
| |||||||||||||||||||||||||||||
Grade 1 (Mild) | Grade 2 (Moderate) | Grade 3 (Severe) | |||||||||||||||||||||||||||
❑ NPO ❑ IVF & correct electrolyte abnormalities ❑ IV antibiotics (full dose) ❑ IV pain management w/ analgesics ❑ Assess severity
| ❑ NPO ❑ IVF & correct electrolyte abnormalities ❑ IV antibiotics (full dose) ❑ IV pain management w/ analgesics ❑ Assess severity ❑ Immediate biliary tract drainage within 24-48 hours | ❑ NPO ❑ IVF & correct electrolyte abnormalities ❑ IV antibiotics (full dose) ❑ IV pain management w/ analgesics ❑ Assess severity ❑ Immediate organ support
| |||||||||||||||||||||||||||
Improvement | No improvement within the first 24 hours | ||||||||||||||||||||||||||||
Finish antibiotic course | Immediate biliary tract drainage within 24 hours | ||||||||||||||||||||||||||||
Treatment for etiology if still needed (endoscopic treatment, percutaneous treatment, or operative intervention) | |||||||||||||||||||||||||||||
- ↑ 1.0 1.1 Mayumi, T.; Someya, K.; Ootubo, H.; Takama, T.; Kido, T.; Kamezaki, F.; Yoshida, M.; Takada, T. (2013). "Progression of Tokyo Guidelines and Japanese Guidelines for management of acute cholangitis and cholecystitis". J UOEH. 35 (4): 249–57. PMID 24334691. Unknown parameter
|month=
ignored (help) - ↑ Solomkin, JS.; Mazuski, JE.; Baron, EJ.; Sawyer, RG.; Nathens, AB.; DiPiro, JT.; Buchman, T.; Dellinger, EP.; Jernigan, J. (2003). "Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections". Clin Infect Dis. 37 (8): 997–1005. doi:10.1086/378702. PMID 14523762. Unknown parameter
|month=
ignored (help)